BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24927053)

  • 1. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
    Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
    Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
    Karabanovich G; Němeček J; Valášková L; Carazo A; Konečná K; Stolaříková J; Hrabálek A; Pavliš O; Pávek P; Vávrová K; Roh J; Klimešová V
    Eur J Med Chem; 2017 Jan; 126():369-383. PubMed ID: 27907875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
    Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
    ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
    Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
    Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
    Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
    Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
    Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities.
    Ding Z; Hou P; Liu B
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
    Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
    J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
    Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
    Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
    Karabanovich G; Dušek J; Savková K; Pavliš O; Pávková I; Korábečný J; Kučera T; Kočová Vlčková H; Huszár S; Konyariková Z; Konečná K; Jand'ourek O; Stolaříková J; Korduláková J; Vávrová K; Pávek P; Klimešová V; Hrabálek A; Mikušová K; Roh J
    J Med Chem; 2019 Sep; 62(17):8115-8139. PubMed ID: 31393122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.